Real-Time Clinical Guidance for Dialysis Cannulation
A treatment-integrated system that guides site selection, avoids hazards, and standardizes cannulation—at the moment of care.
Not documentation. Not retrospective review. Active clinical decision support during dialysis treatment.
Veristra™, is an FDA Breakthrough Device that provides real-time clinical decision support for cannulation site selection and hazard avoidance during dialysis treatment.
Real-Time Clinical Decision Support
Veristra™ delivers point-of-care guidance during cannulation, transforming prior access use into actionable insight for safer decision-making.
By providing a real-time visual understanding of access utilization, clinicians can:
- Avoid overused and high-risk zones
- Identify safer, underutilized regions
- Maintain more consistent and uniform cannulation practices
Point-of-Care Cannulation Guidance
Guided Site Selection
Real-time visualization of prior access use to support safer, more informed needle placement
Clinical Decision Support at the Chair
Provides immediate guidance during treament to reduce variability and improve cannulation consistency
Patient-Specific Access Intelligence
Transforms each patient’s access history into a visual guide for individualized care.
Collaborative Integration Cross-Disciplinary Visibility
Supports communication between dilaysis staff and vascular specialists through shared access visualization.
Standardization & Quality Alignment
Promotes consistent technique and supports alignment with evolving quality and value-based care initiatives.
We offer an attractive, capital-efficient SaaS model with long-term data value potential.
Our leadership team includes experienced clinicians, a technologists, and healthcare entrepreneurs committed to impact and scale.
